Condition
Recurrent Myelodysplastic/Myeloproliferative Neoplasm clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Recurrent Myelodysplastic/Myeloproliferative Neoplasm clinical trials that are recruiting, in United States. By phase: Phase 1 (2), Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Recurrent Myelodysplastic/Myeloproliferative Neoplasm clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Axatilimab with or without azacitidine for adults with advanced myeloproliferative neoplasms or high‑risk CMML | Phase 1/2 | Columbus, Ohio and 1 other locations | Recruiting | Jul 26, 2024 |
| Onvansertib treatment for recurrent or refractory chronic myelomonocytic leukemia and related conditions | Phase 1 | Rochester, Minnesota | Recruiting | Sep 22, 2022 |
| Combining azacitidine, venetoclax, and gilteritinib for treating FLT3-mutated blood cancers | Phase 1/2 | Houston, Texas | Recruiting | Oct 28, 2019 |
| Using edetate calcium disodium or succimer to treat acute myeloid leukemia or myelodysplastic syndrome during chemotherapy | Phase 1 | Houston, Texas | Recruiting | Aug 15, 2018 |
All recruiting trials (4)
-
Axatilimab with or without azacitidine for adults with advanced myeloproliferative neoplasms or high‑risk CMML
This trial tests whether the antibody axatilimab, alone or together with the chemotherapy azacitidine, can help adults with advanced‑phase myeloproliferative neoplasms, MPN/MDS overlap, or high‑risk chronic myelomonocytic leukemia (CMML).
-
Onvansertib treatment for recurrent or refractory chronic myelomonocytic leukemia and related conditions
This study is testing a new drug called onvansertib to see if it can help people with recurring chronic myelomonocytic leukemia and related blood disorders feel better and respond to treatment.
-
Combining azacitidine, venetoclax, and gilteritinib for treating FLT3-mutated blood cancers
This study is testing a new combination of three medications to see if they can help people with certain types of blood cancers that have a specific genetic mutation.
-
Using edetate calcium disodium or succimer to treat acute myeloid leukemia or myelodysplastic syndrome during chemotherapy
This study is testing whether two drugs, edetate calcium disodium and succimer, can safely help people with acute myeloid leukemia or myelodysplastic syndrome feel better during chemotherapy.
Related topics
Quick answers
How many Recurrent Myelodysplastic/Myeloproliferative Neoplasm clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.